Description
YUSIMRY (adalimumab-aqvh) is a prescription biologic drug that blocks tumor necrosis factor, a protein involved in inflammation. It's a monoclonal antibody used to treat autoimmune conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Administered as a subcutaneous injection, each dose contains 40 mg of the active ingredient. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Adalimumab-aqvh — ANDA 761216 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761216 |
Tags
- drug-safety
- drug-information
- public-health
- prescription-drugs
- drug